Total Funding
$170M
Employee Range
51-100
Kyverna Therapeutics is revolutionizing autoimmune disease treatment with innovative therapies. Their groundbreaking approach aims to provide cures for serious conditions, offering hope for patients worldwide.
Kyverna Therapeutics data powered by:
Share
Kyverna Therapeutics data powered by:
Kyverna TherapeuticsOverall Ranking
National Rank
Share
Loading...
In United States
Top null%out of startups
Regional Rank
Share
Loading...
In North America
Top null%out of startups
Kyverna TherapeuticsIndustry Rankings in
Healthtech
City Rank
Share
3rd
In Berkeley
Top 7%out of 49 startups
National Rank
Share
580th
In United States
Top 7%out of 8869 startups
Regional Rank
Share
599th
In North America
Top 7%out of 9666 startups
Kyverna TherapeuticsSubindustry Rankings in
BiotechnologyCity Rank
Share
2nd
In Berkeley
Top 7%out of 32 startups
National Rank
Share
169th
In United States
Top 5%out of 3470 startups
Regional Rank
Share
174th
In North America
Top 5%out of 3719 startups
rankings by:
Kyverna TherapeuticsSB Rank Evolution
Not enough data points to display the chart.
Kyverna TherapeuticsstartupComparison
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...
See all ranked entities with a premium subscription
Get Pro